PGV001, a personalized cancer vaccine, induced immune responses across various cancer types like breast and urothelial cancer ...

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, ...

Sarclisa is a CD38-directed antibody that is currently approved as an intravenous therapy for relapsed multiple myeloma in combination ... people with advanced breast cancer via the NHS in England ...

A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients have been told that multiple myeloma is treatable but not curable. Yet data ...

Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

Marianne (right) was diagnosed with myeloma when her daughter (left) was just 11 When Marianne Williams was told she had incurable cancer at 43 she knew she had to face it with positivity.